Our team
所在位置: Home > Research > Our team > Content
Prof Liang-Xi XieProfessor, Master supervisor, Chief physician

Prof Liang-Xi Xie is a master supervisor and chief physician. He received his doctoral degree in 2008 and went to Stanford University Cancer Center as a visiting scholar in 2011. He was one of the 2016 Guangdong Provincial Organization Department "Sailing Plan-Training Senior Talents". Currently he is the director of Department of Radiotherapy of Xiang'an Hospital of Xiamen University currently and member of the Professor Committee of Xiamen University. He mainly engaged in the research of precise radiotherapy technology for solid tumors and the mechanism of tumor metastasis. He presided over 3 national, provincial and ministerial scientific research projects, and published more than 10 SCI-listed papers.

Selected publications

1. Xie WJ, Wu X, Xue RL, Lin XY, Kidd EA, Yan SM, Zhang YH, Zhai TT, Lu JY, Wu LL, Zhang H, Huang HH, Chen ZJ, Li DR, Xie LX. More Accurate Definition of Clinical Target Volume Based on the Measurement of Microscopic Extensions of the Primary Tumor Toward the Uterus Body in International Federation of Gynecology and Obstetrics Ib-IIa Squamous Cell Carcinoma of the Cervix, Int J Radiat Oncol Biol Phys, 2015, 91(1): 206-12.

2. Lu JY, Cheung Michael Lok Man, Li M, Huang BT, Xie WJ, Xie LX. Dosimetric Evaluation of a Simple Planning Technique forImproving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer, PLos One,2 015, 10(7): e0129461.

3. Dong H, Xie L, Tang C, Chen S, Liu Q, Zhang Q, Zheng W, Zheng Z, Zhang H. Snail1 correlates with patient outcomes in E-cadherin-preservedgastroesophageal junction adenocarcinoma, Clin Transl Oncol, 2014, 16(9): 783-91.

4. Xie LX, Zhai TT, Yang LP, Eleano Yang, Zhang XH, Chen JY, Zhang H. Lymphangiogenesis and Prognostic Significanceof Vascular Endothelial Growth Factor-C (VEGF-C) in Gastroesophageal Junction Adenocarcinoma (GEJA), Int J Exp Pathol, 2013, 94(1): 39-46.


Copyrights © 2020 Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer / The Key Laboratory for Endocrine-Related Cancer Precision Medicine of Xiamen. All rights reserved. Republication or redistribution of material on this website is prohibited without the prior written consent of Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer / The Key Laboratory for Endocrine-Related Cancer Precision Medicine of Xiamen.

The information and contents on this website are provided for general information purposes and references only, and on the understanding that no any medical/academic advice or recommendation is being rendered or given. All information and contents are not warranted to be absolutely correct, accurate, complete or up-to-date. All materials and functions are not warranted to be uninterrupted, error-free or virus/harmful element-free. We are entitled to delete, suspend or edit any information (including but not limited to service details and charges), contents and materials and stop any functions from time to time without prior notice or giving any reasons. We accept NO responsibility for any losses, damages or misunderstandings incurred for any causes whatsoever in relation to or as a result of the use of this website.

Top